baber/WOPTO huggingface dataset:
Patent AU-600816-B2 (AU)
Title: 4-demethoxy-4-amino-anthracyclines
Inventor: CARUSO MICHELE
IPC: C07C225/34
Filed: 1988-04-15
Granted: 1990-08-23
Abstract: Anthracycline glycosides of formula (I) and their pharmaceutically acceptable acid addn. salts are new where R1 = H or OH; one of R2 and R3 = H, the other is H or OH. Also new are the intermediates 4-demethoxy-4-amino -7-deoxy-daunomycinone (IX) and daunomycinones (II), opt. N-protected. - (I) is pref. 4-demethoxy-4 -amino-daunorubicin; 4-demethoxy- 4-amino-4'-epi-daunorubicin or 4-demethoxy-4-amino -4'-deoxy-daunorubicin, and the corresp. doxorubicin cpds.
Patent AU-684895-B2 (AU)
Title: Brake disc for rail vehicles
Inventor: DELLMANN TORSTEN
IPC: C22C32/00
Filed: 1995-01-07
Granted: 1998-01-08
Abstract: An axle or wheel brake disk for rail vehicles is designed as a monobloc disk or as a disk formed by a hub (2) or segments and by a friction ring (1), preferably provided with inner ventilation and having hard ceramic particles distributed in an aluminium alloy matrix. The invention consists in that at least the friction ring (1), preferably also the cooling ribs (3) linked thereto and/or also the hub (2) or segments are made of a sub-eutectic AlSi base alloy reinforced by hard ceramic particles.
Patent AU-765304-B2 (AU)
Title: Doppler ultrasound method and apparatus for monitoring blood flow
Inventor: MOEHRING MARK A
IPC: G01S7/52
Filed: 1999-11-12
Granted: 2003-09-11
Abstract: A pulse Doppler ultrasound system and associated methods are described for monitoring blood flow. A graphical information display includes simultaneously displayed depth-mode and spectrogram displays. The depth-mode display indicates the various positions along the ultrasound beam axis at which blood flow is detected. These positions are indicated as one or more colored regions, with the color indicating direction of blood flow and varying in intensity as a function of detected Doppler ultrasound signal amplitude or detected blood flow velocity. The depth-mode display also includes a pointer whose position may be selected by a user. The spectrogram displayed corresponds to the location identified by the pointer. Embolus detection and characterization are also provided.
Patent AU-747942-B2 (AU)
Title: Preformed tobacco package
Inventor: BERG EWOUD ALFONSES
IPC: A24F23/02
Filed: 1999-03-02
Granted: 2002-05-30
Abstract: The invention relates to a package for tobacco comprising a substantially rectangular bag, provided with a front side (5) and a rear side (1) fixedly interconnected on three lateral sides (7',7'',7''';8',8'',8'''), and wherein the fourth side (9) can form an opening, while on the rear side (1), at the location of the opening, a flap (3) connects, characterized in that the front (5) side and/or rear side (1) consists of a preformed plastic sheet. <IMAGE>
Patent AU-664036-B2 (AU)
Title: Process for the production of activated sialic acids
Inventor: KITTELMANN MATTHIAS
IPC: C12N1/21
Filed: 1992-07-16
Granted: 1995-11-02
Abstract: The invention relates to a process for the preparation of cytidine-5'-monophosphosialic acids, characterised in that a sialic acid is reacted with cytidine-5'-triphosphate in the presence of a cell extract, which has optionally been subjected to a purification step, of a naturally occurring microorganism with cytidine-5'-monophospho-N-acetylneuraminate synthetase activity.
Patent AU-707440-B2 (AU)
Title: Antibodies against E-selectin
Inventor: OWENS RAYMOND JOHN
IPC: A61K39/395
Filed: 1995-03-28
Granted: 1999-07-08
Abstract: This invention relates to whole antibodies of neutral isotype having specificity for E-selection, process for their preparation (using vectors), pharmaceutical compositions containing them, and their use in therapy (e.g. for inflammatory disorders) and diagnosis. Said antibodies are variants of natural antibodies altered in the Fc region, especially in the CH2 domain, so that the interactions with antibodies Fc receptors and complement are absent or very low.
Patent AU-696681-B2 (AU)
Title: Method for quantitatively determining cholesterol
Inventor: HINO KOUICHI
IPC: G01N33/53
Filed: 1995-04-03
Granted: 1998-09-17
Abstract: A method for quantitatively determining cholesterol in high density lipoproteins, in which, prior to the determination of cholesterol by an enzymatic method, a surfactant and a substance which forms a complex with lipoproteins other than high density lipoproteins are added to a sample containing lipoproteins. The method does not require any pretreatments such as centrifugal separation. With a simple operation, cholesterol in HDLs can be measured effectively. Also, this method can be adopted in a variety of automated analyzers, and thus is very useful in the field of clinical assays.
Patent AU-690255-B2 (AU)
Title: Process for peptide segment condensation
Inventor: HO GUO-JIE
IPC: C07C233/00
Filed: 1995-03-31
Granted: 1998-04-23
Abstract: The present invention is drawn to a process for forming an amide bond linkage comprising reacting a carboxylic acid and an amine in a two-phase mixture of water and an organic solvent selected from an oxygenated organic solvent or an aromatic solvent in the presence of a coupling reagent and an additive. This process is useful for making ubiquitous amides and polypeptides having various biological activities.
Patent AU-771236-B2 (AU)
Title: Teat cup assembly
Inventor: MILBRATH CONSTANCE J
IPC: A01J5/08
Filed: 2000-12-18
Granted: 2004-03-18
Abstract: A teat cup assembly for use with a milking machine for milking cows. The teat cup assembly comprises a hollow tubular shell together with an inflation including a hollow tubular barrel disposed within the shell. The inflation is deformable between a relaxed profile and a collapsed massage profile around the teat of a cow. The teat cup assembly includes reinforcing structure for predetermining a desired collapsed massage profile for the barrel of the inflation. The reinforcing structure includes a plurality of circumferentially spaced ribs projecting from the barrel of the inflation, and a corresponding plurality of rib receiving grooves formed in the inner surface of the shell. As a result, the inflation will always collapse in a known and predetermined massage profile, which is preferably triangular in shape, to override any inherent inconsistencies in manufacturing processes or materials of construction.
Patent AU-690272-B2 (AU)
Title: Movable upper tool for the separation of the blanks from a sheet which is processed by a press that manufactures packages
Inventor: DOMPIERRE JOHN BERNARD DE
IPC: B26F1/44
Filed: 1995-07-10
Granted: 1998-04-23
Abstract: The tool comprises a base plate (3) having openings (5), from the lower face (24) of which are fixed punches (4,4a). The openings are located along two orthogonal axes, one of which is inclined relative to one of the tool base plate edges at an angle between fifteen and twenty degrees. The tool works with a lower tool separating the cut-out sheets (2). The punches deform under the pressure engendered by downward displacement of the upper tool and meet a solid separation bar (9). One of the lateral faces of the punch section is tangent to one of the openings so that the pitch between the punches provides an identical total pressure from them, on the cut-out to be separated, near one lower tool separation bar, whatever the position occupied by the separation bars. The non-separated sheet has a front nipped piece (22) gripped by pincers (23) which transport this sheet to the cut-out separation and reception station. <IMAGE>
Patent AU-688552-B2 (AU)
Title: Dinucleoside-5',5'-pyrophosphates
Inventor: FLORA ANTONIO DE
IPC: A61P35/00
Filed: 1995-07-10
Granted: 1998-03-12
Abstract: 5',5'-Pyrophosphates of non-naturally occurring nucleosides selected from thymine-3'-azido-2',3'-dideoxy-D-riboside, 5-fluorouracil-2'-deoxy-D-riboside, uracil-3'-azido-2',3'-dideoxy-D-riboside, guanine-2',3'-dideoxy-D-riboside, hypoxanthing-2',3'-dideoxy-D-riboside, cytosine-2',3'-dideoxy-D-riboside, and adenine-2',3'-dideoxy-D-riboside, are described as well as their manufacture and use as therapeutical pharmaceutical compositions or as pro-drugs encapsulated into biological carriers, e.g., transformed erythrocytes, for targeting to specific cell population responsible of the development of the pathological disorders.
Patent AU-674837-B2 (AU)
Title: Method and apparatus for treating tissue damage
Inventor: ARGENTA LOUIS C
IPC: A61B19/00
Filed: 1992-11-12
Granted: 1997-01-16
Abstract: The invention disclosed is a method of treating tissue damage comprising applying a negative pressure to a wound sufficient in time and magnitude to promote tissue migration and thus facilitate closure of the wound. The method is applicable to wounds, burns, infected wounds, and live tissue attachments. Configurations of apparatus for carrying out the method are also disclosed.
Patent AU-671970-B2 (AU)
Title: Method and ring-opened purine compounds for labeling polynucleotides
Inventor: MCCABE MEAD M
IPC: C12Q1/68
Filed: 1992-12-03
Granted: 1996-09-19
Abstract: The invention provides methods for attaching detectable labels to the N7-formyl group, of imidazole ring-opened alkylated purines and purine derivatives, directly, through a linking group, or by subsequent derivatization of a blocking group. The invention provides simple and efficient methods for labeling polynucleotides. In addition, the invention provides derivatized ring-opened alkylated purines and purine derivatives, including reagents for chemical and enzymatic synthesis of detectably labeled polynucleotides.
Patent AU-549867-B2 (AU)
Title: Improving television picture quality by activity-controlled dpcm-coding
Inventor: STARCK ALEXANDER
IPC: H04N19/503
Filed: 1984-09-14
Granted: 1986-02-20
Abstract: A method for improving picture quality given DPCM coded television signals provides for the determination of an activity criterion from the video values of the same television field which surround a current sample and the video signal values of the preceding television field by calculation of the intensity differences between the video signal values. The estimated value is determined from the video signal values of the most recent television field, from the video signal values of the most recent and current television fields, or only from the video signal values of the current television fields, as a function of two thresholds.
Patent AU-659287-B2 (AU)
Title: Process for the continuous casting of metal, in particular steel for producing billets and blooms
Inventor: KAWA FRANCISZEK
IPC: B22D11/00
Filed: 1993-02-17
Granted: 1995-05-11
Abstract: Molten steel is continuously teemed into a casting passage to establish a bath of molten steel in the passage. The molten steel is partially solidified in the casting passage to form a strand having a plurality of bulges which are uniformly distributed circumferentially of the strand. The strand is continuously withdrawn from the casting passage and the bulges are deformed during strand withdrawal so as to reduce bulge size. The amount of deformation is regulated by varying the bath level as a function of one or more casting parameters.
Patent AU-726112-B2 (AU)
Title: Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition
Inventor: LEENHEER LEEN DE
IPC: A23P30/40
Filed: 1997-07-25
Granted: 2000-11-02
Abstract: A method for preparing a polydispersed saccharide composition in which a fructan-containing material is dissolved in water prior to partial enzymatic treatment of the fructans.
Patent AU-718891-B2 (AU)
Title: Automatic lead switching for ECG monitor
Inventor: DONEHOO ROBERT E
IPC: A61B5/276
Filed: 1997-10-06
Granted: 2000-04-20
Abstract: A multi-lead ECG monitor (10) determines whether the reference electrode (LA) has been disconnected and, if so, switches to another reference electrode, which is selected in accordance with a predetermined priority scheme, to continue ECG monitoring. Disconnection of the reference electrode can be determined by observing that no ECG signal is being received from any of the electrodes. After a stabilization period, the system then determines if any electrodes are still connected. If not, then, as before, it is determined that the new reference electrode is not connected and that a new reference electrode needs to be selected. The switching of the reference electrode continues in this manner until it is determined that electrodes are connected. If sufficient electrodes (LA,RA,LL,RL,CA,CB) including the new reference electrode are still connected to the patient to permit ECG monitoring, then ECG monitoring continues and a status message is presented to the operator identifying which electrodes are disconnected. Once complete electrode connection is regained, the ECG monitor automatically switches back to the preferred settings with the desired reference electrode. <IMAGE>
Patent AU-664902-B2 (AU)
Title: Improvements in and relating to collection devices
Inventor: TURNBULL KENNETH JAMES
IPC: A47L5/14
Filed: 1993-06-22
Granted: 1995-12-07
Abstract: In more detail the apparatus comprises a duct for transporting material entrained in a stream of pressurised primary air from a collection mouth at an upstream end of the duct to a downstream region of the duct for collection. at least one primary air inlet opening into the duct for delivering pressurised air to form a primary air stream directed generally downstream of the duct, at least one secondary air outlet for delivering pressurised air to form a secondary air stream directed onto an area of the surface confronting the collection mouth, the secondary air stream serving to dislodge material on the said confronting area for entrainment in the primary air stream and transportation from the collection mouth to the downstream region of the duct for collection.
Patent AU-659013-B2 (AU)
Title: Process for producing particles and coating films of titanium oxide
Inventor: OKADA MIZUHO
IPC: C01G23/047
Filed: 1993-07-26
Granted: 1995-05-04
Abstract: The present invention relates to a method of using titanium oxide particles as a photocatalyst, said titanium oxide particles being obtained by subjecting titanium oxide fine particles to a hydrothermal treatment at a temperature of 100 DEG C or higher to carry out crystal growth of the fine particles.
Patent AU-668188-B2 (AU)
Title: Plastic blow molded freestanding container
Inventor: YOUNG WILLIAM C
IPC: B65D1/02
Filed: 1993-06-09
Granted: 1996-04-26
Abstract: A plastic blow molded container (10) is disclosed as including a freestanding base structure (20) that is constructed with a plurality of alternating hollow legs 22 and curved ribs (34), and a hub (41) from which the legs and ribs extend radially with a construction that provides good stability against tipping as well as the capability of withstanding internal pressure. Each rib (34) has an outer upper end (36) with a circumferential width Wu and an inner lower end (38) with a circumferential width Wl that is greater than the circumferential width Wu of the upper rib end so the lower rib end is capable of resisting stress cracking. An intermediate rib portion (40) of a curved shape tapers between the ends with an included angle B in the range of about 1 degrees to 8 degrees and preferably about 2 degrees.
Patent AU-562807-B2 (AU)
Title: Tetrapeptides
Inventor: HEAVNER GEORGE
IPC: C07K/
Filed: 1985-07-31
Granted: 1987-06-18
Abstract: Solution phase methods and compositions for preparing H-ARG-X-Z-Y-TYR-R wherein X is LYS and Y is VAL or X and Y are both SAR, Z is ASP or GLU, and R is NH<sub>2</sub> or OH.
Patent AU-621427-B2 (AU)
Title: Process for the production of a sintered denture
Inventor: LANGE THOMAS
IPC: A61C13/10
Filed: 1989-12-12
Granted: 1992-03-12
Abstract: A method of producing a sintered, very high density dental prosthesis from a suspension containing noble-metal powder mixtures with bi or multimodal particle-size distribution and a mixing liquid. The suspension is molded to the desired shape and then the dental prosthesis is dried. The molded dental prosthesis is then heat-treated 5 to 45 minutes between 100 DEG  and 400 DEG  C., then heated with an average temperature elevation of 50 to 300 K/min. to 800 DEG  C. and then brought to the sintering temperature T at 20 to 200 K/min. The sintering temperature T is between Tsolidus - 200) and Tsolidus - 70), whereby Tsolidus is the solidus temperature of the sintered alloy. The cooling-down of the dental prosthesis takes place under a vacuum or a protective gas.
Patent AU-715305-B2 (AU)
Title: Thrombin inhibitors
Inventor: COBURN CRAIG
IPC: A61K31/551
Filed: 1997-10-20
Granted: 2000-01-20
Abstract: A compound which inhibits human thrombin and which has structure (a) such as (b).
Patent AU-716620-B2 (AU)
Title: Epoxysuccinic acid derivatives
Inventor: NOMURA YUTAKA
IPC: C07D303/48
Filed: 1996-04-01
Granted: 2000-03-02
Abstract: <CHEM> Epoxysuccinic acid derivatives having general formula (I) (wherein R<1> represents hydrogen, alkyl, aryl or aralkyl; R<2> and R<3> independently represent each aryl, aralkyl or alkyl; and X represents -O-or NR<4>- wherein R<4> represents hydrogen, alkyl or aralkyl) which is useful in the prevention or treatment of bone diseases such as osteoporosis, malignant hypercalcemia, and bone Behcet's disease, in the treatment of osteoarthritis and rheumatoid arthritis in association with the abnormal hyperergasia of cathepsin L activity, and as a remedy for diseases in which cathepsins L and B participate such as muscular dystrophy and amyotrophy.
Patent AU-675087-B2 (AU)
Title: 4-quinolinyl derivatives with anti-helicobacter activity
Inventor: VENET MARC GASTON
IPC: C07D521/00
Filed: 1993-10-19
Granted: 1997-01-23
Abstract: PCT No. PCT/EP93/02884 Sec. 371 Date Apr. 4, 1995 Sec. 102(e) Date Apr. 4, 1995 PCT Filed Oct. 19, 1993 PCT Pub. No. WO94/10164 PCT Pub. Date May 11, 1994The present invention is concerned with novel quinoline derivatives having anti-Helicobacter activity of formula    <IMAGE>  (I)  the pharmaceutically acceptable acid addition salts thereof, the stereochemically isomeric forms thereof, the quaternized forms thereof and the +E,uns N+EE -oxides thereof, wherein -A- represents a bivalent radical of formula -N=CH-CH=CH-(a), -CH=N-CH=CH-(b), -N=N-CH=CH-(c), -N=CH-N=CH-(d), -N=CH-CH=N-(e), -CH=N-N=CH-(f), -N=N-N=CH-(g), -N=N-CH=N-(h), or -CH=CH-CH=CH-(i); R1, R2, R3, R4, R5, R6 and R7 each independently represent hydrogen, halo, hydroxy, C1-4alkyloxy, C1-4alkyl, trifluoromethyl, amino, mono- or di(C1-4alkyl)amino or nitro, provided that when one substituent on a phenyl group is a nitro then the other substituents on said phenyl group are other than nitro; novel compositions comprising said compounds, processes of preparing said compounds and compositions and methods for treating subjects suffering from disorders or afflictions associated with Helicobacter infection.
Patent AU-775592-B2 (AU)
Title: Device for removal of calculi
Inventor: HIRT JOACHIM
IPC: A61B17/22
Filed: 2001-06-14
Granted: 2004-08-05
Abstract: Device for removal of calculi by using an intracorporeal lithotripter comprises a metallic probe or sonotrode which is excited by an electrically controlled ultrasonic transducer for generating longitudinal oscillations for the fragmentation of calculi via the distal end of the sonotrode, the sonotrode accommodating a coaxially arranged impact probe which for an alternative fragmentation of calculi transfers shock or pressure forces that are generated by the impact energy of a reversibly driven impact member or projectile which periodically hits against a mass body on the proximal end of the impact probe when its drive is alternatively switched-on.
Patent AU-628147-B2 (AU)
Title: Modular coupling for use in frameworks, scaffoldings and the like
Inventor: SWOBODA HELLMUTH
IPC: E04B1/19
Filed: 1990-03-26
Granted: 1992-09-10
Abstract: To connect the individual bars (2) and supports (3), if any are present, of a framework structure, connectors having in a customary manner connector openings (4) and connector projections (5) are provided. In order that the connection process and also the detachment of the connection can be carried out as simply and quickly as possible and nevertheless a secure and firm connection can be obtained, retaining pins (6) which can be laterally deflected counter to a restoring force are provided inside the particular connector opening (4), within the clear cross-section thereof. The connector projection (5) which fits into the connector opening (4) has a sloping face (7) or tip which, on insertion, impinges on and moves apart these retaining pins (6) and, adjoining said oblique face or tip, an aperture (8) which recedes radially with respect to the largest cross-section of the connector projection (5) and into which the retaining pins (6) can thus spring back again, with the result that the first loose connection is already made. Adjacent to this aperture (8) in the circumferential direction there are provided regions (9) which, on relative rotation of the connector projection (5), deflect the retaining pins (6) in turn radially as far as the outer dimension of the connector projection (5), so that the connector projection (5) can be very easily drawn out of the opening (4) again or, conversely, the opening (4) can be very easily withdrawn from the projection (5). To secure the play-endowed connection, there is furthermore provided in the region of the connector projection (5) a sliding or screw sleeve (11) which, in the connected position, can be adjusted and locked relative to the surface region adjacent to the connector joint, with the result that the connector projection (5) and especially the radial boundary (8a) of its aperture (8) is clamped against the retaining pin (6) counter to the insertion direction. 
<IMAGE>
Patent AU-781094-B2 (AU)
Title: Antisense to c-myc for treatment of polycystic kidney disease
Inventor: IVERSEN PATRICK L
IPC: A61K31/711
Filed: 2000-05-24
Granted: 2005-05-05
Abstract: A method of treating polycystic kidney disease by administering an oligonucleotide antisense to <i>c-myc</i> is described. The antisense oligonucleotide is preferably a morpholino oligonucleotide.
Patent AU-675680-B2 (AU)
Title: Fibrinogen receptor antagonists
Inventor: HARTMAN G D
IPC: C07D209/10
Filed: 1993-10-12
Granted: 1997-02-13
Abstract: PCT No. PCT/US93/09730 Sec. 371 Date May 31, 1995 Sec. 102(e) Date May 31, 1995 PCT Filed Oct. 12, 1993 PCT Pub. No. WO94/08962 PCT Pub. Date Apr. 28, 1994Fibrinogen receptor antagonists of the formula:   <IMAGE>   wherein A,B,D,E,Y are as defined in the specification, are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
Patent AU-637099-B2 (AU)
Title: 2,5-Diazabicyclo-(2.2.1) heptane derivatives
IPC: C07D207/16
Filed: 1990-05-10
Granted: 1993-05-20
Abstract: Diazabicyclo[2.2.1]heptane intermediates are prepared from 4-hydroxy-L-proline in a five step procedure, or from allo-4-hydroxy-D-proline, through a novel 2-(C1-c6)alkyl-5-substituted-2,5-diazabicyclo[2.2.1]heptane intermediate. The diazabicycloheptanes are of use in the preparation of antibiotic quinolones.
Patent AU-696468-B2 (AU)
Title: Transaction recovery in a value transfer system
Inventor: EVERETT DAVID BARRINGTON
IPC: G06Q40/02
Filed: 1996-05-14
Granted: 1998-09-10
Abstract: PCT No. PCT/GB96/01146 Sec. 371 Date Jan. 27, 1988 Sec. 102(e) Date Jan. 27, 1988 PCT Filed May 14, 1996 PCT Pub. No. WO96/36947 PCT Pub. Date Nov. 21, 1996A value transfer system for transferring value in transactions between electronic purses as electronic cash has a transaction failure recovery procedure whereby a pending log stores transaction messages after they are sent. On detection of an error an interface device (IFD) can issue a payment resume command to re-send the last transaction message and resume the transaction.